Wednesday, April 16, 2025

Sharp uptake in use of new weight loss and glucose-lowering medications

Researchers found that by December 2023, more than 1 in 3 of the medications being started for type 2 diabetes treatment were GLP-1RA-based medications.

from Top Health News -- ScienceDaily https://ift.tt/eDV8R6n
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Natural hormone unlocks a hidden fat burning switch

FGF19 triggers the brain to burn more energy and activate fat-burning cells, offering a potential new path for obesity treatments. The hormo...